Medical technology has undergone a fundamental transformation. We have left behind the days when medical instruments were isolated tools – today they are nodes in a global nervous system.
In 2025, the Internet of Medical Things (IoMT) passed a historic milestone:
- Market valuation: over $70 billion
- Everything from surgical platforms to wearables generate constant, massive data streams
The new headache for medtech companies
It is no longer enough to build a great product. The challenge is how to manage, process and secure the data that the product generates every second.
Moving from periodic data collection to continuous real-time monitoring requires infrastructure that most companies are not built for.
The bottleneck: from lab to production
| Lab environment | Production requirements |
|---|---|
| Controlled test environment | Thousands of hospitals at the same time |
| Secondary latencies | Millisecond latency |
| Isolated systems | Global connectivity |
This requires robust AI infrastructure and a mature MLOps approach that can manage the full lifecycle of medical data.
Data sovereignty: an absolute necessity
In medtech, data sovereignty is not just a buzzword – it is a legal and ethical imperative.
Regulations affecting Swedish medtech companies:
- GDPR – complete control over patient data
- AI Regulation – transparency and traceability requirements
- Jurisdiction – where data is processed and stored
Relying blindly on public cloud services under foreign jurisdiction is a risk that few dare to take in the long run.
Aixia’s role: The invisible spine
As an infrastructure partner, we help medtech companies build the critical backbone for their IoMT solutions:
- GPU power for training and inference of advanced models
- Swedish data centers – full data sovereignty
- Real-time processing – Edge to cloud
- Secure storage solutions – encrypted and redundant
Architecture with a focus on sovereignty:
We offer a complete chain from edge devices at the patient bedside to GPU clusters in our secure data centers. Sensors collect data in real-time, our data centers handle AI processing with MLOps pipelines, and the result is clinical decision support with millisecond precision – all under Swedish jurisdiction.
Winners of the future
The winners of the future in medical technology will not just be those with the best sensors or the sharpest optics.
They will be the ones who succeed:
- Taming their data streams
- Turning them into clinical insights
- Doing it in real time
- With full security and sovereignty
Building that capability requires an infrastructure as sophisticated as the medical instruments themselves.
Let’s talk IoMT
Is your company facing the challenge of scaling up an IoMT platform or securing real-time processing of sensitive medical data?
At Aixia, we have the experience to build the environments required for the next generation of medical technology.
Contact us to discuss how we can support your journey towards safer and smarter care.
Aixia – Your partner for AI infrastructure and data sovereignty.
